OrphanDrug
OrphanDrug
Pharma Knowledge Base

Acute myeloblastic leukemia with maturation

ORPHA: 98834

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Classification & Codes

Overview

acute myeloid leukemia (AML) characterized by blasts with evidence of maturation to more mature neutrophils (WHO, 2001)

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Classification & Codes

Orphanet Code

ORPHA:98834
Acute myeloblastic leukemia with maturation
OrphanetORPHA:98834
Treatments0 drug(s)
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO
Acute myeloblastic leukemia with maturation | OrphanDrug